Howard Shelanski

Howard Shelanski earned his B.A. from Haverford College and received his J.D. and Ph.D. in economics from the University of California at Berkeley. After graduating from law school he clerked for Judge Stephen F. Williams of the U.S. Court of Appeals for the D.C. Circuit, Judge Louis H. Pollak of the U.S. District Court in Philadelphia, and Justice Antonin Scalia of the United States Supreme Court. After practicing law in Washington, D.C., Professor Shelanski joined the Berkeley faculty in 1997, where he remained until coming to Georgetown in 2011.

Professor Shelanski has held several positions in the federal government. From 2013 to 2017, he served as Administrator of the White House Office of Information and Regulatory Affairs (OIRA). Before President Obama nominated him to OIRA, Professor Shelanski was Director of the Bureau of Economics at the Federal Trade Commission from 2012 to 2013, where he had previously been Deputy Director from 2009 to 2011. Earlier in his career, he was Chief Economist of the Federal Communications Commission (1999-2000) and a Senior Economist for the President’s Council of Economic Advisers at the White House (1998-1999).

In addition to being a member of the Georgetown Law faculty, Professor Shelanski practices antitrust law and is a member of the law firm of Davis Polk & Wardwell LLP.

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More